Pathogenesis of atopic dermatitis
Eung Ho Choi, Na Young Yoon
J Korean Med Assoc. 2014;57(3):218-225.   Published online 2014 Mar 13     DOI: https://doi.org/10.5124/jkma.2014.57.3.218
Citations to this article as recorded by Crossref logo
Effects of Apigenin on RBL-2H3, RAW264.7, and HaCaT Cells: Anti-Allergic, Anti-Inflammatory, and Skin-Protective Activities
Che-Hwon Park, Seon-Young Min, Hye-Won Yu, Kyungmin Kim, Suyeong Kim, Hye-Ja Lee, Ji-Hye Kim, Young-Jin Park
International Journal of Molecular Sciences.2020; 21(13): 4620.     CrossRef
Omalizumab for atopic dermatitis: evidence for and against its use
Jesper G. Holm, Simon F. Thomsen
Giornale Italiano di Dermatologia e Venereologia.2019;[Epub]     CrossRef
Pathophysiologie der atopischen Blepharokeratokonjunktivitis
T. Lapp, P. Maier, T. Jakob, T. Reinhard
Der Ophthalmologe.2017; 114(6): 504.     CrossRef
Omalizumab for atopic dermatitis: case series and a systematic review of the literature
Jesper Grønlund Holm, Tove Agner, Carsten Sand, Simon Francis Thomsen
International Journal of Dermatology.2017; 56(1): 18.     CrossRef